913 related articles for article (PubMed ID: 15298047)
1. Association between paraoxonase-1 activity and lipid peroxidation indicator levels in people living in the Antalya region with angiographically documented coronary artery disease.
Göçmen AY; Gümüşlü S; Semiz E
Clin Cardiol; 2004 Jul; 27(7):426-30. PubMed ID: 15298047
[TBL] [Abstract][Full Text] [Related]
2. Is elevated serum ceruloplasmin level associated with increased risk of coronary artery disease?
Göçmen AY; Sahin E; Semiz E; Gümuşlü S
Can J Cardiol; 2008 Mar; 24(3):209-12. PubMed ID: 18340391
[TBL] [Abstract][Full Text] [Related]
3. Age, Sex, and Cardiovascular Risk Attributable to Lipoprotein Cholesterol Among Chinese Individuals with Coronary Artery Disease: A Case-Control Study.
Wu TT; Zheng YY; Yang YN; Li XM; Ma YT; Xie X
Metab Syndr Relat Disord; 2019 May; 17(4):223-231. PubMed ID: 30720383
[No Abstract] [Full Text] [Related]
4. Relationship between paraoxonase-1 (PON1) activity and lipoprotein (a) levels in Turkish coronary artery disease patients living in the Antalya region.
Göçmen YA; Semiz E; Gümüşlü S
Eur J Cardiovasc Prev Rehabil; 2005 Apr; 12(2):185-6. PubMed ID: 15785307
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein B and coronary artery disease in women: a cross-sectional study in women undergoing their first coronary angiography.
Westerveld HT; van Lennep JE; van Lennep HW; Liem AH; de Boo JA; van der Schouw YT; Erkelens DW
Arterioscler Thromb Vasc Biol; 1998 Jul; 18(7):1101-7. PubMed ID: 9672070
[TBL] [Abstract][Full Text] [Related]
6. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F
Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641
[TBL] [Abstract][Full Text] [Related]
7. Abnormalities in the relationship of paraoxonase 1 with HDL and apolipoprotein A1 and their possible connection to HDL dysfunctionality in type 2 diabetes.
Viktorinova A; Jurkovicova I; Fabryova L; Kinova S; Koren M; Stecova A; Svitekova K
Diabetes Res Clin Pract; 2018 Jun; 140():174-182. PubMed ID: 29626583
[TBL] [Abstract][Full Text] [Related]
8. Paraoxonase (PON1) activity in north west Indian Punjabis with coronary artery disease & type 2 diabetes mellitus.
Singh S; Venketesh S; Verma JS; Verma M; Lellamma CO; Goel RC
Indian J Med Res; 2007 Jun; 125(6):783-7. PubMed ID: 17704557
[TBL] [Abstract][Full Text] [Related]
9. Activation of paraoxonase 1 is associated with HDL remodeling ex vivo.
Gugliucci A
Clin Chim Acta; 2014 Feb; 429():38-45. PubMed ID: 24280342
[TBL] [Abstract][Full Text] [Related]
10. Associations of lipid measures with total occlusion in patients with established coronary artery disease: a cross-sectional study.
Li T; Yuan D; Wang P; Jia S; Zhang C; Zhu P; Song Y; Tang X; Zhao X; Gao Z; Yang Y; Gao R; Xu B; Yuan J
Lipids Health Dis; 2022 Nov; 21(1):118. PubMed ID: 36369093
[TBL] [Abstract][Full Text] [Related]
11. PON1 activity is inversely related to LDL apoB carbonyl content in patients with coronary artery disease.
Sharma R; Singh B; Mahajan M
Kaohsiung J Med Sci; 2007 May; 23(5):225-31. PubMed ID: 17525004
[TBL] [Abstract][Full Text] [Related]
12. Visceral leishmaniasis is associated with marked changes in serum lipid profile.
Liberopoulos EN; Apostolou F; Gazi IF; Kostara C; Bairaktari ET; Tselepis AD; Elisaf M
Eur J Clin Invest; 2014 Aug; 44(8):719-27. PubMed ID: 24920396
[TBL] [Abstract][Full Text] [Related]
13. Paraoxonase 1 (PON1) 55 polymorphism, lipid profiles and psoriasis.
Asefi M; Vaisi-Raygani A; Bahrehmand F; Kiani A; Rahimi Z; Nomani H; Ebrahimi A; Tavilani H; Pourmotabbed T
Br J Dermatol; 2012 Dec; 167(6):1279-86. PubMed ID: 22835076
[TBL] [Abstract][Full Text] [Related]
14. The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk.
Walldius G; Jungner I; Aastveit AH; Holme I; Furberg CD; Sniderman AD
Clin Chem Lab Med; 2004; 42(12):1355-63. PubMed ID: 15576296
[TBL] [Abstract][Full Text] [Related]
15. Gender-specific association of coronary artery calcium and lipoprotein parameters: the Heinz Nixdorf Recall Study.
Erbel R; Lehmann N; Churzidse S; Möhlenkamp S; Moebus S; Mahabadi AA; Schmermund A; Stang A; Dragano N; Grönemeyer D; Seibel R; Kälsch H; Bauer M; Bröcker-Preuss M; Mann K; Jöckel KH;
Atherosclerosis; 2013 Aug; 229(2):531-40. PubMed ID: 23701995
[TBL] [Abstract][Full Text] [Related]
16. Bariatric surgery improves lipoprotein profile in morbidly obese patients by reducing LDL cholesterol, apoB, and SAA/PON1 ratio, increasing HDL cholesterol, but has no effect on cholesterol efflux capacity.
Kjellmo CA; Karlsson H; Nestvold TK; Ljunggren S; Cederbrant K; Marcusson-Ståhl M; Mathisen M; Lappegård KT; Hovland A
J Clin Lipidol; 2018; 12(1):193-202. PubMed ID: 29146227
[TBL] [Abstract][Full Text] [Related]
17. Improved risk assessment of coronary artery disease by substituting paraoxonase 1 activity for HDL-C: Novel cardiometabolic biomarkers based on HDL functionality.
Mahrooz A; Shokri Y; Variji A; Zargari M; Alizadeh A; Mehtarian E
Nutr Metab Cardiovasc Dis; 2021 Apr; 31(4):1166-1176. PubMed ID: 33579580
[TBL] [Abstract][Full Text] [Related]
18. Coronary artery disease is associated with the ratio of apolipoprotein A-I/B and serum concentration of apolipoprotein B, but not with paraoxonase enzyme activity in Iranian subjects.
Rahmani M; Raiszadeh F; Allahverdian S; Kiaii S; Navab M; Azizi F
Atherosclerosis; 2002 Jun; 162(2):381-9. PubMed ID: 11996958
[TBL] [Abstract][Full Text] [Related]
19. Relationship between selected oxidative stress markers and lipid risk factors for cardiovascular disease in middle-aged adults and its possible clinical relevance.
Viktorinova A; Svitekova K; Stecova A; Krizko M
Clin Biochem; 2016 Aug; 49(12):868-72. PubMed ID: 27240017
[TBL] [Abstract][Full Text] [Related]
20. Association of serum amyloid A and oxidative stress with paraoxonase 1 in sarcoidosis patients.
Ivanišević J; Kotur-Stevuljević J; Stefanović A; Spasić S; Vučinić Mihailović V; Videnović Ivanov J; Jelić-Ivanović Z
Eur J Clin Invest; 2016 May; 46(5):418-24. PubMed ID: 26919159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
